Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Fosun Pharma 2021 Annual Results Announcement: Accelerating the Globalization Comprehensively 2022-03-23 06:53
WuXi Biologics Achieved Record Growth and Profitability in 2021 2022-03-23 00:38
INDICAID COVID-19 Rapid Antigen At-Home Test Receives FDA Emergency Use Authorization (EUA) for Over-the-Counter (OTC), Asymptomatic, Non- Prescription Use 2022-03-23 00:00
Cyclobenzaprine: positive opinion from EMA in Rapid Scientific Advice procedure as a possible anti-Covid-19 therapy 2022-03-22 22:12
CanSinoBIO's Convidecia™ Approved as Heterologous Booster in Malaysia and Indonesia 2022-03-22 21:32
Detecting COVID-19 using only a smartphone 2022-03-22 11:37
Nuance Pharma Announces License and Supply Agreement with Bavarian Nordic on the Development and Commercialization of Respiratory Syncytial Virus (RSV) Vaccine for Adults in China and Selected Asian Markets 2022-03-21 16:20
Progresses Made in Series of Studies of Prevention and Control of COVID-19 with Lianhua Qingwen Capsules 2022-03-21 15:56
Zepp Health Releases 2021 International Sleep White Paper 2022-03-18 19:30
Joint Fight Against COVID-19, Viva Biotech Contributes to the Production of the Oral COVID-19 Antiviral Medication and Virus Tests 2022-03-18 17:47
Ping An Reports Steady YoY Growth of 6.1% in Operating Profit Attributable to Shareholders of the Parent Company in 2021 2022-03-17 22:54
BioVaxys Announces Bioproduction of BVX-1021 for its Pan-Sarbecovirus Program in Collaboration with The Ohio State University 2022-03-17 20:18
First eye drops registered on the Australian Register of Therapeutic Goods (ARTG) to slow the progression of short-sightedness now available for children aged from 4 to 14 years old[1] 2022-03-17 17:00
MGI Helps Combat COVID-19 Pandemic in Laos with Innovative Container Laboratory Thanks to the Support of LSEA 2022-03-17 14:00
Adagene Announces FDA Clearance to Proceed with Phase 1b/2 Trial of Anti-CTLA-4 ADG126 SAFEbody® in Combination Therapy With Anti-PD-1 Antibody Pembrolizumab 2022-03-16 19:00
Beyond a platform, Ping An Good Doctor aiming to be a pillar of China's healthcare sector 2022-03-16 15:17
Pasture Announces First Halal-Certified Surgical N95 Masks for Healthcare and Public Use 2022-03-16 13:00
Brii Bio Announces that National Health Commission of China Adds Amubarvimab/Romlusevimab Combination to its COVID-19 Diagnosis and Treatment Guidelines (9th Pilot Edition) 2022-03-16 09:00
Korea Health Industry Development Institute operates Korean Pavilion at 'HIMSS Global Health Conference & Exhibition' 2022-03-16 06:44
Business Update on ASC10, an Oral Double Prodrug against COVID-19 2022-03-15 19:55
1 52 53 54 55 56 229